Marie E. Fallon is Officer of Ginkgo Bioworks Holdings, Inc.. Currently has a direct ownership of 183,010 shares of DNA, which is worth approximately $1.14 Million. The most recent transaction as insider was on May 02, 2023, when has been sold 8,073 shares (Class A Common Stock) at a price of $1.15 per share, resulting in proceeds of $9,283. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 183K
0% 3M change
0% 12M change
Total Value Held $1.14 Million

Marie E. Fallon Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 02 2023
SELL
Open market or private sale
$9,283 $1.15 p/Share
8,073 Reduced 4.22%
183,010 Class A Common Stock
May 01 2023
BUY
Exercise of conversion of derivative security
-
17,740 Added 8.5%
191,083 Class A Common Stock
Apr 03 2023
SELL
Open market or private sale
$11,089 $1.27 p/Share
8,732 Reduced 4.8%
173,343 Class A Common Stock
Mar 31 2023
BUY
Exercise of conversion of derivative security
-
17,741 Added 8.88%
182,075 Class A Common Stock
Mar 02 2023
SELL
Open market or private sale
$9,743 $1.33 p/Share
7,326 Reduced 4.27%
164,334 Class A Common Stock
Mar 01 2023
BUY
Exercise of conversion of derivative security
-
13,990 Added 7.54%
171,660 Class A Common Stock
Feb 02 2023
SELL
Open market or private sale
$13,910 $2.15 p/Share
6,470 Reduced 3.94%
157,670 Class A Common Stock
Feb 01 2023
BUY
Exercise of conversion of derivative security
-
13,990 Added 7.85%
164,140 Class A Common Stock
Jan 04 2023
SELL
Open market or private sale
$12,324 $1.56 p/Share
7,900 Reduced 5.0%
150,150 Class A Common Stock
Jan 03 2023
BUY
Exercise of conversion of derivative security
-
15,657 Added 9.01%
158,050 Class A Common Stock
Dec 02 2022
SELL
Open market or private sale
$11,981 $1.94 p/Share
6,176 Reduced 4.16%
142,393 Class A Common Stock
Dec 01 2022
BUY
Exercise of conversion of derivative security
-
13,657 Added 8.42%
148,569 Class A Common Stock
Nov 03 2022
SELL
Open market or private sale
$16,576 $2.64 p/Share
6,279 Reduced 4.45%
134,912 Class A Common Stock
Nov 01 2022
BUY
Exercise of conversion of derivative security
-
13,657 Added 8.82%
141,191 Class A Common Stock
Oct 06 2022
SELL
Open market or private sale
$332,326 $3.25 p/Share
102,254 Reduced 44.5%
127,534 Class A Common Stock
Oct 03 2022
SELL
Open market or private sale
$8,493 $3.12 p/Share
2,722 Reduced 0.55%
494,217 Class A Common Stock
Sep 30 2022
BUY
Exercise of conversion of derivative security
-
6,134 Added 50.0%
6,134 Class A Common Stock
Oct 01 2021
BUY
Exercise of conversion of derivative security
-
490,805 Added 49.69%
496,939 Class A Common Stock
MEF

Marie E. Fallon

Officer
Boston, MA

Track Institutional and Insider Activities on DNA

Follow Ginkgo Bioworks Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNA shares.

Notify only if

Insider Trading

Get notified when an Ginkgo Bioworks Holdings, Inc. insider buys or sells DNA shares.

Notify only if

News

Receive news related to Ginkgo Bioworks Holdings, Inc.

Track Activities on DNA